So-called coronavirus "long-haulers" — patients who suffer from COVID-19 symptoms for an extended period of time — are causing the medical community to re-evaluate the disease, Ed Yong reports for The Atlantic.
For instance, many studies have found that COVID-19 patients produce antibodies that appear to last months as a result of their infection, but The Atlantic notes that most of these studies focused either on hospitalized patients or those who had mild symptoms and swift recoveries. Long-haulers appear to be in a slightly different category, in which their bouts with the virus are defined more by its persistence, rather than severity. At least one survey led by David Putrino, a neuroscientist and rehabilitation specialist at Mount Sinai Hospital in New York, found that despite having symptoms consistent with COVID-19, nearly two-thirds of the 1,400 patients received negative results on their antibody tests.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
Why Spain's economy is boomingThe Explainer Immigration, tourism and cheap energy driving best growth figures in Europe
-
5 trips where the journey is the best partThe Week Recommends Slow down and enjoy the ride
-
5 tax deductions to know if you are self-employedThe explainer You may be able to claim home office, health insurance and other tax deductions
-
Ozempic can curb alcohol cravings, study findsSpeed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
-
New form of H5N1 bird flu found in US dairy cowsSpeed Read This new form of bird flu is different from the version that spread through herds in the last year
-
Microplastics accumulating in human brains, study findsSpeed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
-
FDA approves painkiller said to thwart addictionSpeed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
-
Study finds possible alternative abortion pillSpeed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
-
California declares bird flu emergencySpeed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
-
Bird flu one mutuation from human threat, study findsSpeed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
-
Dark chocolate tied to lower diabetes riskSpeed Read The findings were based on the diets of about 192,000 US adults over 34 years
